Mineralocorticoid receptor antagonist added to angiotensin-converting enzyme inhibitor ameliorates the transition to diastolic heart failure by decreasing myocardial oxidative stress

被引：0
|
作者：
Kimata, H
Obata, K
Saka, M
Cheng, XW
Hayashi, K
Ichihara, S
机构：
[1] Nagoya Univ, Nagoya, Aichi, Japan
[2] Mie Univ, Tsu, Mie 514, Japan
来源：
CIRCULATION | 2005年 / 112卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2183
引用
收藏
页码：U512 / U512
页数：1
相关论文
共 50 条
  • [31] Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction
    Yu, CM
    Tipoe, GL
    Lai, KWH
    Lau, CP
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (04) : 1207 - 1215
  • [32] Use of Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Risk of Dementia in Heart Failure
    Chitnis, Abhishek S.
    Aparasu, Rajender R.
    Chen, Hua
    Kunik, Mark E.
    Schulz, Paul E.
    Johnson, Michael L.
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2016, 31 (05): : 395 - 404
  • [33] USE OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS AND RISK OF DEMENTIA IN HEART FAILURE
    Chitnis, A. S.
    Johnson, M. L.
    Aparasu, R. R.
    Chen, H.
    Kunik, M. E.
    Schulz, P. E.
    VALUE IN HEALTH, 2013, 16 (03) : A11 - A11
  • [34] Impact of angiotensin-converting enzyme inhibitor dosage on outcomes in elderly patients with heart failure
    Hannah, EL
    Pederson, JC
    Snyder, JJ
    Moormeier, J
    Ellerbeck, EF
    CIRCULATION, 1999, 100 (18) : 782 - 782
  • [35] Factors determining angiotensin-converting enzyme inhibitor underutilization in heart failure in a community setting
    Philbin, EF
    CLINICAL CARDIOLOGY, 1998, 21 (02) : 103 - 108
  • [36] Comparison of angiotensin-converting enzyme inhibitor alone and in combination with irbesartan for the treatment of heart failure
    Kum, Leo Chi-Chiu
    Yip, Gabriel Wai-Kwok
    Lee, Pui-Wai
    Lam, Yat-Yin
    Wu, Eugene B.
    Chan, Anna Kin-Yin
    Fung, Jeffrey Wing-Hong
    Chan, Joseph Yat-Sun
    Zhang, Qing
    Kong, Shun-Ling
    Yu, Cheuk-Man
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 125 (01) : 16 - 21
  • [37] Physician adjudication of angioedema in patients with heart failure on angiotensin-converting enzyme inhibitor therapy
    Johnson, Eric S.
    Thorp, Micah L.
    Go, Alan S.
    Lee, Mingsum S.
    Shen, Albert Y. J.
    Park, Ken J.
    Budzynska, Katarzyna
    Markin, Abraham
    Sung, Sue H.
    Thompson, Jamie H.
    Yang, Xiuhai
    An, Jaejin
    Reynolds, Kristi
    Roblin, Douglas W.
    Cassidy-Bushrow, Andrea E.
    Schlienger, Raymond
    Behr, Sigrid
    Smith, David H.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 155 - 156
  • [38] Is optimal angiotensin-converting enzyme inhibitor dosing neglected in elderly patients with heart failure?
    Gattis, WA
    Larsen, RL
    Hasselblad, V
    Bart, BA
    O'Connor, CM
    AMERICAN HEART JOURNAL, 1998, 136 (01) : 43 - 48
  • [39] Angiotensin-converting enzyme inhibitor use in older patients with heart failure and renal dysfunction
    Philbin, EF
    Santella, RN
    Rocco, TA
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (03) : 302 - 308
  • [40] Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure
    Luzier, AB
    Forrest, A
    Adelman, M
    Hawari, FI
    Schentag, JJ
    Izzo, JL
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (04): : 465 - 469
12345